124 related articles for article (PubMed ID: 30829267)
1. Correlation between human leukocyte antigen-G expression and clinical parameters in oral squamous cell carcinoma.
Shen X; Wang P; Dai P; Jin B; Tong Y; Lin H; Shi G
Indian J Cancer; 2018; 55(4):340-343. PubMed ID: 30829267
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
3. HLA-G Expression is Associated with an Unfavorable Prognosis of Oral Squamous Cell Carcinoma.
Imani R; Seyedmajidi M; Ghasemi N; Moslemi D; Shafaee S; Bijani A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2527-2533. PubMed ID: 30256047
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical investigations on the expression of programmed cell death ligand 1, human leukocyte antigens G and E, and granzyme B in intraoral mucoepidermoid carcinoma.
Mosconi C; Arantes DAC; Gonçalves AS; Alencar RCG; Oliveira JC; Silva TA; Mendonça EF; Batista AC
Arch Oral Biol; 2017 Nov; 83():55-62. PubMed ID: 28711734
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
7. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
9. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva.
Gonçalves AS; Arantes DA; Bernardes VF; Jaeger F; Silva JM; Silva TA; Aguiar MC; Batista AC
Hum Immunol; 2015 Jan; 76(1):52-8. PubMed ID: 25500427
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathologic significance of the expression of HLA-G in oral squamous cell carcinoma.
Gonçalves AS; Wastowski IJ; Capeletti LR; Sacono NT; Cortez AP; Valadares MC; Silva TA; Batista AC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):361-8. PubMed ID: 24528793
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer.
Hsieh SC; Kuo SN; Zheng YH; Tsai MH; Lin YS; Lin JH
Anticancer Res; 2013 Nov; 33(11):4965-73. PubMed ID: 24222137
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma.
Koike K; Dehari H; Shimizu S; Nishiyama K; Sonoda T; Ogi K; Kobayashi J; Sasaki T; Sasaya T; Tsuchihashi K; Tsukahara T; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
Cancer Sci; 2020 May; 111(5):1491-1499. PubMed ID: 32167621
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
15. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.
Ota K; Fujimori H; Ueda M; Jono H; Shinriki S; Ota T; Sueyoshi T; Taura M; Taguma A; Kai H; Shinohara M; Ando Y
Int J Oncol; 2010 Oct; 37(4):797-804. PubMed ID: 20811700
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
17. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
19. Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Kato A; Hirai M; Yanase M; Yoshimoto T; Kimura I; Sugiura S; Okamune A; Kitahara H; Noguchi N; Kato K; Ueki K; Kawashiri S
Oncol Rep; 2013 Feb; 29(2):445-50. PubMed ID: 23229436
[TBL] [Abstract][Full Text] [Related]
20. A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma.
Ries J; Mollaoglu N; Toyoshima T; Vairaktaris E; Neukam FW; Ponader S; Nkenke E
Dis Markers; 2009; 27(2):75-84. PubMed ID: 19893202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
